236 related articles for article (PubMed ID: 24570560)
41. Should we operate on microscopic N2 non-small cell lung cancer?
Fontaine E; McShane J; Carr M; Shackcloth M; Mediratta N; Page R; Poullis M
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):956-61; discussion 961. PubMed ID: 21330443
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
[TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of superior sulcus tumors: results and prognostic factors.
Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
[TBL] [Abstract][Full Text] [Related]
44. Should males ever undergo wedge resection for stage 1 non-small-cell lung cancer? A propensity analysis.
Mediratta N; Shackcloth M; Page R; Woolley S; Asante-Siaw J; Poullis M
Eur J Cardiothorac Surg; 2014 Aug; 46(2):267-73; discussion 273. PubMed ID: 24420371
[TBL] [Abstract][Full Text] [Related]
45. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
Ludwig C; Stoelben E; Olschewski M; Hasse J
Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
[TBL] [Abstract][Full Text] [Related]
46. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
Mansour Z; Kochetkova EA; Santelmo N; Ducrocq X; Quoix E; Wihlm JM; Massard G
Ann Thorac Surg; 2008 Jul; 86(1):228-33. PubMed ID: 18573428
[TBL] [Abstract][Full Text] [Related]
47. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer.
Ng T; Ryder BA; Chern H; Sellke FW; Machan JT; Harrington DT; Cioffi WG
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):815-9. PubMed ID: 22325327
[TBL] [Abstract][Full Text] [Related]
48. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
[TBL] [Abstract][Full Text] [Related]
49. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
[TBL] [Abstract][Full Text] [Related]
50. [Results of pneumonectomy for non-small cell lung cancer in Iceland].
Thorsteinsson H; Jonsson S; Alfredsson H; Isaksson HJ; Gudbjartsson T
Laeknabladid; 2009 Dec; 95(12):823-9. PubMed ID: 19996469
[TBL] [Abstract][Full Text] [Related]
51. En bloc resection of non-small-cell lung cancer invading the spine.
Schirren J; Dönges T; Melzer M; Schönmayr R; Eberlein M; Bölükbas S
Eur J Cardiothorac Surg; 2011 Sep; 40(3):647-54. PubMed ID: 21334220
[TBL] [Abstract][Full Text] [Related]
52. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
53. [Clinical analysis of operation combined chemotherapy for stage IIIa non-small cell lung cancer].
Wang W; Li H; Shang LQ; Li XC; Li J; Song WA; Wen F
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1450-2. PubMed ID: 16318812
[TBL] [Abstract][Full Text] [Related]
54. [Prognosis of non-small cell lung cancer patients with microscopic residual disease at bronchial stump after lung resection].
Dai W; Yu C; Sun Y
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1022-4. PubMed ID: 12194790
[TBL] [Abstract][Full Text] [Related]
55. Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer.
Hata A; Sekine Y; Kota O; Koh E; Yoshino I
Int J Chron Obstruct Pulmon Dis; 2016; 11():1261-8. PubMed ID: 27354784
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
57. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer.
Spaggiari L; D' Aiuto M; Veronesi G; Pelosi G; de Pas T; Catalano G; de Braud F
Ann Thorac Surg; 2005 Jan; 79(1):234-40. PubMed ID: 15620949
[TBL] [Abstract][Full Text] [Related]
58. Should aggressive surgery ever be part of the management of small cell lung cancer?
Waddell TK; Shepherd FA
Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
[TBL] [Abstract][Full Text] [Related]
59. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
[TBL] [Abstract][Full Text] [Related]
60. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
